HK1207002A1 - 用於治療細菌感染的包含抗細菌噬菌體的混合物的組合物及其使用方法 - Google Patents

用於治療細菌感染的包含抗細菌噬菌體的混合物的組合物及其使用方法

Info

Publication number
HK1207002A1
HK1207002A1 HK15107764.2A HK15107764A HK1207002A1 HK 1207002 A1 HK1207002 A1 HK 1207002A1 HK 15107764 A HK15107764 A HK 15107764A HK 1207002 A1 HK1207002 A1 HK 1207002A1
Authority
HK
Hong Kong
Prior art keywords
cocktails
compositions
treatment
bacterial infections
phages
Prior art date
Application number
HK15107764.2A
Other languages
English (en)
Inventor
Mendes Joao Joao Duarte Alves
Leandro Clara Isabel Rodrigues
Corte-Real Sofia Volker
Original Assignee
Tecnifar Ind Tecnica Farmaceutica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnifar Ind Tecnica Farmaceutica S A filed Critical Tecnifar Ind Tecnica Farmaceutica S A
Publication of HK1207002A1 publication Critical patent/HK1207002A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/32—Surgical cutting instruments
    • A61B17/3205—Excision instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/32—Surgical cutting instruments
    • A61B2017/320004—Surgical cutting instruments abrasive
    • A61B2017/320008—Scrapers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
HK15107764.2A 2012-03-19 2015-08-11 用於治療細菌感染的包含抗細菌噬菌體的混合物的組合物及其使用方法 HK1207002A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261612531P 2012-03-19 2012-03-19
PCT/PT2013/000016 WO2013141730A1 (en) 2012-03-19 2013-03-19 Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections

Publications (1)

Publication Number Publication Date
HK1207002A1 true HK1207002A1 (zh) 2016-01-22

Family

ID=48534472

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107764.2A HK1207002A1 (zh) 2012-03-19 2015-08-11 用於治療細菌感染的包含抗細菌噬菌體的混合物的組合物及其使用方法

Country Status (14)

Country Link
US (1) US9962419B2 (zh)
EP (1) EP2833899B1 (zh)
JP (1) JP6186427B2 (zh)
CN (1) CN104519893B (zh)
AU (1) AU2013235883B2 (zh)
BR (1) BR112014023321B1 (zh)
CA (1) CA2867418C (zh)
DK (1) DK2833899T3 (zh)
ES (1) ES2814024T3 (zh)
HK (1) HK1207002A1 (zh)
PT (1) PT2833899T (zh)
RU (1) RU2654596C2 (zh)
SG (1) SG11201405829WA (zh)
WO (1) WO2013141730A1 (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2865383A1 (en) * 2013-10-25 2015-04-29 Pherecydes Pharma Phage therapy of pseudomonas infections
WO2016066722A2 (en) * 2014-10-28 2016-05-06 Ian Humphery-Smith Bacteriophage combinations for human or animal therapy
US10455983B2 (en) 2015-09-10 2019-10-29 Prince Castle LLC Modular food holding system
US20170157186A1 (en) * 2015-12-02 2017-06-08 Smart Phage, Inc. Phage to treat bacteria on skin
WO2017180862A1 (en) * 2016-04-13 2017-10-19 Northeast Ohio Medical University Gpnmb compositions for treatment of skin wounds
CA3045284A1 (en) 2016-12-05 2018-06-14 Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa Bacteriophage compositions comprising respiratory antibacterial phages and methods of use thereof
EP3679579A1 (en) * 2017-09-05 2020-07-15 Adaptive Phage Therapeutics, Inc. Methods to determine the sensitivity profile of a bacterial strain to a therapeutic composition
MX2020004251A (es) * 2017-10-19 2021-05-27 Mona E Buice Composición tópica para cicatrización mejorada de heridas abiertas.
CN111448616A (zh) * 2017-12-11 2020-07-24 自适应噬菌体治疗公司 噬菌体分配系统
EP3735275A1 (en) * 2018-01-02 2020-11-11 Armata Pharmaceuticals, Inc. Therapeutics bacteriophage compositions for treating staphylococcus infection
CN109082414B (zh) * 2018-06-29 2020-11-13 浙江工业大学 一种金黄色葡萄球菌噬菌体及应用
CA3107463A1 (en) 2018-07-24 2020-01-30 Medimmune, Llc Antibody directed against s. aureus clumping factor a (clfa)
CN109730235A (zh) * 2019-02-01 2019-05-10 珠海横琴普罗恩能医用食品有限公司 一种用于医用食品的防腐剂
WO2020237044A1 (en) * 2019-05-21 2020-11-26 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Bacteriophages for the treatment of tuberculosis
CN111643724B (zh) * 2020-07-01 2022-01-28 南京大学 一种载有噬菌体和酸性成纤维细胞生长因子的水凝胶伤口敷料的制备方法及其应用
WO2022013314A1 (en) 2020-07-14 2022-01-20 Biontech R&D (Austria) Gmbh Bacteriophage cocktails and uses thereof
WO2022013318A1 (en) 2020-07-14 2022-01-20 Biontech R&D (Austria) Gmbh New mosaic bacteriophages and uses thereof
CN112251439B (zh) * 2020-10-26 2022-06-21 齐鲁师范学院 拟南芥高温诱导启动子pHTG1及其重组载体
CN112301001B (zh) * 2020-11-03 2022-10-14 华中农业大学 金黄色葡萄球菌噬菌体lsa2311及其应用
CN113201458B (zh) * 2020-12-21 2022-05-27 青岛诺安百特生物技术有限公司 一种提高噬菌体制剂稳定性的组合物及其应用
CA3218291A1 (en) * 2021-05-12 2022-11-17 Lior Moshe ZELCBUCH Staphylococcus bacteriophage and uses thereof
DE202022102100U1 (de) 2022-04-20 2022-04-27 Prabhakar Ramesh Bhandari Synergistische antibiotische pharmazeutische Zusammensetzung zur Behandlung von Staphylococcus aureus-Infektionen
WO2024115430A1 (en) * 2022-11-28 2024-06-06 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Acinetobacter baumannii phages

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995027043A1 (en) 1994-04-05 1995-10-12 Exponential Biotherapies, Inc. Antibacterial therapy with genotypically modified bacteriophage
US5863560A (en) 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US6138401A (en) 1999-06-25 2000-10-31 Duncan; Franklin R. Fish hook remover
DE60315636T2 (de) 2002-03-25 2008-05-08 University Of Warwick, Coventry Zur therapie und prophylaxe bakterieller infektionen geeignete bakteriophagen
US20050095222A1 (en) 2003-10-29 2005-05-05 Taro Suzuki Allergen inhibitor, allergen-inhibiting method, allergen-inhibiting fiber and allergen-inhibiting sheet
CA2586619A1 (en) 2004-11-02 2006-05-11 Gangagen Life Sciences Inc. Bacteriophage compositions
BRPI0515825A (pt) 2004-11-02 2008-08-05 Gangagen Life Sciences Inc formulações de bacteriófagos estabilizadas
CA2593992A1 (en) 2004-12-06 2006-06-15 Rodney M. Donlan Inhibition of biofilm formation using bacteriophage
US20080260697A1 (en) 2005-05-26 2008-10-23 Gangagen Life Sciences Inc. Bacterial Management in Animal Holding Systems
ES2963904T3 (es) 2009-02-06 2024-04-03 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Fago antibacteriano, péptidos de fago y sus métodos de uso
PT104837A (pt) 2009-11-24 2011-05-24 Technophage Investiga O E Desenvolvimento Em Biotecnologia S A P?ptidos de fagos enteroc?cicos e m?todos para a sua utiliza??o
AU2011302722B2 (en) * 2010-09-17 2016-05-26 Technophage, Investigação E Desenvolvimento Em Biotecnologia, S.A. Antibacterial phage, phage peptides and methods of use thereof

Also Published As

Publication number Publication date
PT2833899T (pt) 2020-09-15
CN104519893B (zh) 2020-02-07
BR112014023321B1 (pt) 2022-06-14
SG11201405829WA (en) 2014-10-30
BR112014023321A2 (pt) 2022-02-01
EP2833899B1 (en) 2020-06-24
JP6186427B2 (ja) 2017-08-23
WO2013141730A1 (en) 2013-09-26
US9962419B2 (en) 2018-05-08
ES2814024T3 (es) 2021-03-25
AU2013235883A1 (en) 2014-10-02
RU2014141941A (ru) 2016-05-20
DK2833899T3 (da) 2020-09-28
CA2867418A1 (en) 2013-09-26
RU2654596C2 (ru) 2018-05-21
CA2867418C (en) 2020-03-10
EP2833899A1 (en) 2015-02-11
JP2015512384A (ja) 2015-04-27
US20150150919A1 (en) 2015-06-04
AU2013235883B2 (en) 2018-01-04
CN104519893A (zh) 2015-04-15

Similar Documents

Publication Publication Date Title
HK1207002A1 (zh) 用於治療細菌感染的包含抗細菌噬菌體的混合物的組合物及其使用方法
HK1218836A1 (zh) 協同細菌組合物和其製造方法和用途
HK1208799A1 (zh) 針對革蘭氏陽性細菌的噬菌體溶素和抗生素組合
PL2627334T3 (pl) Kompozycje do stosowania w leczeniu zakażeń wirusowych
HK1222398A1 (zh) 治療伯克霍爾德氏菌感染症的組合物及方法
HK1205696A1 (zh) 用於微生物感染的局部治療的組合物
PL2696890T3 (pl) Leczenie infekcji drobnoustrojowych
HK1210018A1 (zh) 用於治療細菌感染的定制脂質體
GB201217097D0 (en) Treatment of bacterial infection
HRP20160150T1 (en) Treatment of streptococcal infections
GB201212588D0 (en) Colicins for treating bacterial infections
HK1202539A1 (zh) -硝呋太爾，其治療感染的用途以及 -硝呋太爾的合成
AP2015008338A0 (en) Compounds for the treatment and prevention of retroviral infections
IL233486A0 (en) Synthetic peptides for the treatment of bacterial infections
HK1207981A1 (zh) 治療和預防金黃色葡萄球菌感染和相關病狀的方法
ZA201503474B (en) Compositions and methods for treating bacterial infections
HK1175786A1 (zh) 合成的 模擬物及其作為用於治療和/或預防革蘭氏陽性菌感染的疫苗成分的用途
PT2862576T (pt) Microrganismos e composições que os compreendem para utilização no tratamento ou prevenção de mastite
EP2529728A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2772248A4 (en) PHARMACEUTICAL COMPOSITION AND KIT FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2670407A4 (en) TREATMENT OF BACTERIAL INFECTIONS
AU2012904839A0 (en) Phage therapy for the treatment of MRSA infections
PT2861214T (pt) Lipossomas adaptados para o tratamento de infeções bacterianas